Skip to main content

Write a PREreview

Transcriptome Analysis of Lung Cancer Staging

Posted
Server
Preprints.org
DOI
10.20944/preprints202510.2391.v1

In this report, we analyzed how the profile of gene over-expression is affected by staging in lung squamous cell carcinoma. We found 23, 62 and 169 genes differentially expressed in stages I, II and III. We also validaded previously reported biomarkers for lung cancer diagnosis (ERCC1, AURKA, TPX2, BIRC5, MET, KLK10, TOP2A, PCNA, KRAS, CCNB1, CEP55, TP53, EGFR, CHEK1, CCNB2, RRM1, CDK1, MCC, UBE2C, AURKB, EXT1, PYCR1). All together, this short report points to the fact lung cancer transcriptome is a potential source for studying tumor staging and progression.

You can write a PREreview of Transcriptome Analysis of Lung Cancer Staging. A PREreview is a review of a preprint and can vary from a few sentences to a lengthy report, similar to a journal-organized peer-review report.

Before you start

We will ask you to log in with your ORCID iD. If you don’t have an iD, you can create one.

What is an ORCID iD?

An ORCID iD is a unique identifier that distinguishes you from everyone with the same or similar name.

Start now